Michael Milyavsky
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion.
Journal: Cell
Published: January 08, 2025
Putting the brakes on cyclin C: a promising strategy to cure B-cell acute lymphoblastic leukemia?
Journal: Haematologica
Published: December 06, 2024
Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia.
Journal: Scientific reports
Published: September 05, 2024
Replication stress responses in human lymphocytes change sex-specifically during aging.
Journal: Nucleic acids research
Published: August 19, 2024
KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition.
Journal: Leukemia
Published: September 14, 2022
T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors.
Journal: Cancer immunology research
Published: May 25, 2022
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG.
Journal: Nature communications
Published: March 07, 2022
Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining.
Journal: Nature communications
Published: June 23, 2020
Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells.
Journal: Nature
Published: October 02, 2019
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators.
Journal: Biochemical pharmacology
Published: May 14, 2019
Last Updated: 09/26/2026